ÃâÒßѧÊÔÌâ
iS<1C`%> Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
?MmQ'1N 1. Fas(CD95)/FasL
m^m=/'<+ 2. common chain of cytokine receptor
DTo"{! 3 . TCR/CD3 complex
Z1+Ewq3m 4. negaive selection of thymocytes
5M #',(X 5. artificial active immune
+opym
!\ 6. anti-idiotypic
KSEKoHJo 7. IgSF
z[R
dM#L 8. Integrin
~]?EV?T
9. chemokine
3$
:F/H 10. B7/CD28
!v9`oL26 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
\+Y=}P> 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
a j
.7t=^ 2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣
O\Z!7UQ$ 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£
T\6,@7 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
*14:^neoI O:T
49:R}r 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
fz|_c*&64 µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
H_x}- Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
j;D$qd'J 1. B7/CD28
.H qJ)OH 2. Th1 subset
N`fFYO 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
xE!0p EHd 4. antibody affinity maturation
~OxFgKn23& 5. AP-1
ZHeq)5C ;f 6. single chain variable fragment£¨ScFv£©
~dLbhjden 7. NK cell receptor
4t/ ?b 8. Zinkernagel-Doherty phenomenon
J9j
@V4 9. Ig fold
3c wBPqH 10. CD40/CD40L
l=Pw
yJ ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
6o9&FU 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£
L;{{P7 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
Fi;OZ>;a 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
FyPG5- Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
/Qef[$!( 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
`l.bU3
C 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
jJt4{c 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£
D2gyn-]\ Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
jA^Dk$ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
WDV=]D/OE Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
HyKA+7} 1.Co-stimulators (or co-stimulating molecules)
B3?rR-2mEE 2.NK-kB
+(afO~9 3.Immunoglobulin superfamily
Yl"CIgt 4.antigen-presenting cell (APC)
zF{~Md1 5.death domain
BtKor6ba 6.CCR and CXCR
+_bxza(ma{ 7.Lectin (or mitogen)
z#P`m,~t0 8.Clusters of differentiation, CD)
B>=D$*_ 9.B7 family
$o\z4_I 10.Cytotoxic T lymphocyte, CTL)
.oTS7rYw 11.IL-15 and IL-15 receptor (IL-15R)
oqhJ2 12.MHC restriction
~OvbMWu 13.Affinity-chromatography
mEi(DW)( 14.Cyctosprin A, CsA
`^'fS@VA 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
"
Y^9g/ ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
]o0]i<: 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
)rAJ>; 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£
!~R<Il|B 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣
wF% RM$ Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
FPF$~ sX ÃâÒßѧרҵ£º
mf{M-(6' 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
GRkN0|ovfj Ïû»¯ÄÚ¿Æ£º
B]() 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
4cPZGZ{U ѪҺ²¡Ñ§×¨Òµ£º
]$9y7Bhj. 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
JR15y3F Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
Yo'Y-h# (רҵ»ù´¡: ÃâÒßѧ)
-Q
JP J. Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
<Z.{q Zd 1. ADCC(antibody dependent cell-mediated cytotoxicity)
gC iM\Qx 2. »·æß¾úËØ(cyclosporin)
C,$o+q*)W9 3. KIR(killer cell inhibitory receptor)
ZS(
%!+ M 4. HLDA(human leucocyte differentiation antigen)
_(8# 5. Interleukin 18(IL-18)
/VufL+q1 6. ÕûºÏËØ(integrin)
ry=8Oq&[~ 7. Fas/FasL
_
A#lyp 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
[TUs^%2@ 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
#Y=b7|l 10. Th1/Th2
`O0Qtq. 11. »ùÒòÒßÃç(DNAÒßÃç)
8OV=;aM?{ 12. chemokines and chemokine receptor
^--R#$X 13. ÃâÒßÄÍÊÜ
T
lkhI 14. ¹²´Ì¼¤·Ö×Ó
U5~aG!E 15. ËÀÍö½á¹¹Óò(death domain)
4;AQ12<[1 ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
M/9[P*
VE 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉË°Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
FGyrDRDwC 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»Æƶø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
KU
oAxA £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
fjy\Q £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
Qb>("j~Z £¨3£©1984Ä꣺ÁÜ°Íϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
^9 LoxU- £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
oi,KA 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄЩÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
% 33O)<? Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
&g23tT#P? ÎÊ´ðÌâ(ÿÌâ25·Ö)
=>3,]hnep 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
y }R2ZO 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
-=8f*K[W 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆһϵͳʵÑé,¼ÓÒÔ֤ʵ¡£
:{Z%dD 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃÇ°¾°¡£